Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria

Jing YANG; Yun ZOU; Qiqi WU; Chaoyang YE; Chen WANG

doi:10.16305/j.1007-1334.2021.2009106

您当前的位置：

首页 >

文章列表页 >

Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria

更新时间：2022-08-03

- Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 2, Pages: 71-75(2021)
- 作者机构：
  
  1.上海中医药大学附属曙光医院肾病科，上海中医药大学中医肾病研究所，上海市中医临床重点实验室，肝肾疾病病证教育部重点实验室（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2009106
  CLC：
扫描看全文
Jing YANG, Yun ZOU, Qiqi WU, et al. Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria. [J]. Shanghai Journal of Traditional Chinese Medicine 55(2):71-75(2021)
DOI：

Jing YANG, Yun ZOU, Qiqi WU, et al. Clinical study on the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases 3-4 stages patients with mild-to-moderate proteinuria. [J]. Shanghai Journal of Traditional Chinese Medicine 55(2):71-75(2021) DOI： 10.16305/j.1007-1334.2021.2009106.

摘要

目的,2,观察肾衰Ⅱ号方对慢性肾脏病（CKD）3-4期轻中度蛋白尿患者的影响。,方法,2,将88例CKD3-4期轻中度蛋白尿患者，随机分为治疗组和对照组，每组44例。两组均予基础治疗，对照组加用尿毒清颗粒，治疗组加用肾衰Ⅱ号方。两组疗程均为6个月，观察临床疗效，比较两组中医症状积分、血肌酐（Scr）、尿素氮（BUN）、肾小球滤过率（eGFR）、24h尿蛋白定量（24hUpro）、尿视黄醇结合蛋白（RBP）、尿α1微球蛋白（α1-MG）、尿β2-微球蛋白（β2-MG）的变化情况。,结果,2,①治疗组、对照组临床总有效率分别为86.36%、61.36%；组间临床疗效比较，治疗组优于对照组（,P,<,0.05）。②治疗前后组内比较，治疗组中医症状各分项积分及总分均较治疗前明显下降（,P,<,0.05），对照组除面色晦暗、恶心呕吐外，其余症状各分项积分及总分明显下降（,P,<,0.05）；组间治疗后比较，除口干口苦外，治疗组症状各分项积分及总分均低于对照组（,P,<,0.05）。③治疗前后组内比较，治疗组Scr、BUN明显下降（,P,<,0.05），eGFR明显上升（,P,<,0.05），对照组Scr明显下降（,P,<,0.05）；组间治疗后比较，治疗组BUN较对照组明显下降（,P,<,0.05）。④治疗前后组内比较，治疗组24hUpro、尿β2-MG、尿α1-MG、尿RBP均明显下降（,P,<,0.05），对照组24hUpro、尿α1-MG明显下降（,P,<,0.05）；组间治疗后比较，治疗组尿β2-MG、尿α1-MG、尿RBP明显低于对照组（,P,<,0.05）。,结论,2,肾衰Ⅱ号方治疗CKD3-4期轻中度蛋白尿的临床疗效优于尿毒清颗粒，能显著改善患者的中医症状、肾功能及肾小管性尿蛋白水平，延缓慢性肾脏病的进展。

Abstract

Objective,2,To observe the effect of Shenshuai Ⅱ Decoction on chronic kidney diseases (CKD) 3-4 patients with mild-to-moderate proteinuria.,Methods,2,A total of 88 patients of CKD3-4 stages with mild-to-moderate proteinuria were randomly divided into control group (44 cases) and treatment group (44 cases). On the basic treatment, the treatment group was treated with Shenshuai Ⅱ Decoction, and the control group was treated with Niaoduqing Granule. The course of treatment in both groups was 6 months. The clinical efficacy and TCM symptom score, renal function (Scr, BUN, eGFR), urine protein (24hUpro, URBP, Uα1-MG, Uβ2-MG)were observed., Results,2,①The total effective rate was 86.36% in the treatment group and 61.36% in the control group, and the clinical efficacy in the treatment group was better than that in the control group(,P,<,0.05). ②After treatment, the single scores and the total scores of TCM symptoms in the treatment group were significantly decreased (,P,<,0.05), while those in the control group were significantly decreased except dark complexion, nausea and vomiting (,P,<,0.05). Except dry mouth and bitter mouth, the single scores and the total scores of TCM symptoms in the treatment group were lower than those in the control group (,P,<,0.05).③After treatment, the levels of Scr and BUN were significantly decreased, and the eGFR level was significantly increased in the treatment group (,P,<,0.05). In the control group, the level of Scr was significantly decreased (,P,<,0.05). The level of BUN was lower in the treatment group than that in the control group (,P,<,0.05). ④After treatment, the levels of 24hUpro, Uβ 2-MG, Uα 1-MG and URBP significantly decreased in the treatment group (,P,<,0.05), while 24hUpro and Uα1-MG decreased significantly in the control group (,P,<,0.05). The levels of Uβ 2-MG, Uα 1-MG and URBP were lower in the treatment group than those in the control group(,P,<,0.05).,Conclusion,2,Shenshuai Ⅱ Decoction has better clinical efficacy than Niaoduqing Granule in the treatment of CKD3-4 patients with mild-to-moderate proteinuria, which significantly improves TCM symptoms and renal function, reduces the level of tubular proteinuria, and delays the progression of CKD.

关键词

慢性肾脏病肾衰Ⅱ号方蛋白尿肾功能临床试验

Keywords

chronic kidney diseaseShenshuai Ⅱ Decoctionproteinuriarenal functionclinic trial

references

PETERSON J C, ADLER S, BURKART J M, et al. Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study[J].Ann Intern Med,1995,123(10): 754-762.

杨婧，严睿俊，王琛. 肾衰Ⅱ号方对慢性肾脏病患者肾功能及炎症因子的影响[J].中国中医药信息杂志,2014,21(12): 15.

WANG M, YANG J, ZHOU Y, et al. ShenShuai Ⅱ recipe attenuates apoptosis and renal fibrosis in chronic kidney disease by increasing renal blood flow and improving oxygen consumption[J].Evid Based Compl Alt,2018(2018): 1-8.

周圆，王琛，何立群，等. 肾衰Ⅱ号方治疗CKD 3-4期患者的临床疗效观察[J].上海中医药大学学报,2011,25(4): 37-40.

KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease[J].Am J Kidney Dis,2007,49(Suppl 2): S12-S154.

国家药品监督管理局. 中药新药临床研究指导原则（试行）[M].北京：中国医药科技出版社，2002: 233-236.

PRABHAKARAN D, ANAND S, WATKINS D, et al. Cardiovascular, respiratory, and related disorders: Key messages from Disease Control Priorities[J].Lancet,2018,391(3): 1224-1236.

XIE Y, BOWE B, MOKDAD A H, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016[J].Kidney Int,2018(94): 567-581.

GLASSOCK R J, WARNOCKD G, DELANAYE P. The global burden of chronic kidney disease: Estimates, variability and pitfalls[J].Nat Rev Nephrol,2017(13): 104-114.

LV J C, ZHANG L X. Prevalence and disease burden of chronic kidney disease[J].Adv Exp Med Biol,2019(1165): 3-15.

OLIVEIRA E A, MAK R H. Progression of chronic kidney disease in children-role of glomerular hemodynamics and interstitial fibrosis[J].Curr Opin Pediatr,2018(30): 220-227.

COZZOLINO M, GENTILE G, MAZZAFERRO S, et al. Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis[J].Am J Kidney Dis,2013,62(5): 984-992.

关子赫，李敬孝. 李敬孝治疗慢性肾功能衰竭蛋白尿验案介绍[J].新中医,2015,47(2): 290-291.

祝婷婷，王琛. 郑平东论治慢性肾炎蛋白尿经验拾萃[J].辽宁中医杂志,2016,43(1): 34-35.

贾安奎，许光霞，刘彦轩. 尿单核细胞趋化蛋白1和尿视黄醇结合蛋白与糖尿肾病的关系[J].中国糖尿病杂志,2010,18(12): 907-909.

AWAD H, EL-BARBARY M, IMAM S, et al. Evaluation of renal glomerular and tubular functional and structural integrity in neonates[J].Am J Med Sci,2002,324(5): 261-266.

Views

301

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical efficacy of Qiyu Qinghua Decoction on proteinuria in chronic kidney disease of spleen-and-kidney qi deficiency type and its effect on inflammatory cytokines

A randomized， double‑blind， placebo‑controlled clinical trial on the external application of Taohong Siwu Decoction to improve the arteriovenous fistula patency during hemodialysis

Effect of Chaihu Shugan Powder plus needling Zusanli （ST 36） on serum inflammatory factors and immune indexes in patients with acute pancreatitis

Clinical observation on acupuncture and traditional Chinese medicine combined treatment of patients with chronic kidney disease stages 2⁃3b and depression

Investigation on traditional Chinese medicine syndrome characteristics in patients with chronic kidney disease and infected with Omicron variant of COVID⁃19

Related Author

No data

Related Institution

Department of Nephrology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Nephrology, Minhang Branch of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Nephrology， Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Traditional Chinese Medicine， Chongming Hospital， Shanghai University of Medicine & Health Sciences

Liangcheng Xincun Street Community Health Service Center of Hongkou District

⁰